Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 4 , Pages 647-664 , December 2006

Genetics of human obesity

  • David M. Mutch, PhD (Post-doctoral researcher)
    • ,
  • Karine Clément, MD, PhD (Professor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +33 1 42 34 8670; Fax: +33 1 40 51 00 57.

References 

  1. Sorensen TI. The genetics of obesity. Metabolism. 1995;44:4
  2. Chung WK, Leibel RL. Molecular physiology of syndromic obesities in humans. Trends in Endocrinology and Metabolism. 2005;16:267
  3. Farooqi IS. Genetic and hereditary aspects of childhood obesity. Best Practice & Research. Clinical Endocrinology & Metabolism. 2005;19:359
  4. OMIM database. http://www.ncbi.nlm.nih.gov/entrez/Query.fcgi?db=OMIM.
  5. Horsthemke B, Buiting K. Imprinting defects on human chromosome 15. Cytogenetic and Genome Research. 2006;113:292
  6. Goldstone AP. Prader–Willi syndrome: advances in genetics, pathophysiology and treatment. Trends in Endocrinology and Metabolism. 2004;15:12
  7. Cummings DE, Clement K, Purnell JQ, et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nature Medicine. 2002;8:643
  8. Zorrilla EP, Iwasaki S, Moss JA, et al. Vaccination against weight gain. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:13226
  9. Franzese A, Romano A, Spagnuolo MI, et al. Growth hormone therapy in children with Prader–Willi syndrome. The Journal of Pediatrics. 2006;148:846;[author reply 846]
  10. Carrel AL, Moerchen V, Myers SE, et al. Growth hormone improves mobility and body composition in infants and toddlers with Prader–Willi syndrome. The Journal of Pediatrics. 2004;145:744
  11. Katsanis N, Lupski JR, Beales PL. Exploring the molecular basis of Bardet–Biedl syndrome. Human Molecular Genetics. 2001;10:2293
  12. Stoetzel C, Laurier V, Davis EE, et al. BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nature Genetics. 2006;38:521
  13. Nishimura DY, Swiderski RE, Searby CC, et al. Comparative genomics and gene expression analysis identifies BBS9, a new Bardet–Biedl syndrome gene. American Journal of Human Genetics. 2005;77:1021
  14. Chiang AP, Beck JS, Yen HJ, et al. Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet–Biedl syndrome gene (BBS11). Proceedings of the National Academy of Sciences of the United States of America. 2006;103:6287
  15. Eichers ER, Lewis RA, Katsanis N, et al. Triallelic inheritance: a bridge between Mendelian and multifactorial traits. Annals of Medicine. 2004;36:262
  16. Slavotinek AM, Searby C, Al-Gazali L, et al. Mutation analysis of the MKKS gene in McKusick-Kaufman syndrome and selected Bardet–Biedl syndrome patients. Human Genetics. 2002;110:561
  17. Fan Y, Esmail MA, Ansley SJ, et al. Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet–Biedl syndrome. Nature Genetics. 2004;36:989
  18. Badano JL, Mitsuma N, Beales PL, et al. The ciliopathies: an emerging class of human genetic disorders. Annual Review of Genomics and Human Genetics. 2006;Epub ahead of print
  19. Singla V, Reiter JF. The primary cilium as the cell's antenna: signaling at a sensory organelle. Science. 2006;313:629
  20. Harrold JA, Williams G. Melanocortin-4 receptors, beta-MSH and leptin: key elements in the satiety pathway. Peptides. 2006;27:365
  21. Strosberg AD, Issad T. The involvement of leptin in humans revealed by mutations in leptin and leptin receptor genes. Trends in Pharmacological Sciences. 1999;20:227
  22. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387:903
  23. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392:398
  24. Krude H, Biebermann H, Schnabel D, et al. Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. The Journal of Clinical Endocrinology and Metabolism. 2003;88:4633
  25. Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nature Genetics. 1997;16:303
  26. Jackson RS, Creemers JW, Farooqi IS, et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. The Journal of Clinical Investigation. 2003;112:1550
  27. Farooqi IS, O'Rahilly S. Monogenic obesity in humans. Annual Review of Medicine. 2005;56:443
  28. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. The Journal of Clinical Investigation. 2002;110:1093
  29. Licinio J, Caglayan S, Ozata M, et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:4531
  30. Williamson DA, Ravussin E, Wong ML, et al. Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy. Appetite. 2005;45:75
  31. Lee YS, Challis BG, Thompson DA, et al. A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metabolism. 2006;3:135
  32. Biebermann H, Castaneda TR, van Landeghem F, et al. A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metabolism. 2006;3:141
  33. Holder JL, Butte NF, Zinn AR. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Human Molecular Genetics. 2000;9:101
  34. Michaud JL, Boucher F, Melnyk A, et al. Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Human Molecular Genetics. 2001;10:1465
  35. Kublaoui BM, Holder JL, Gemelli T, et al. Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons. Molecular Endocrinology. 2006;20:2483
  36. Kernie SG, Liebl DJ, Parada LF. BDNF regulates eating behavior and locomotor activity in mice. The EMBO Journal. 2000;19:1290
  37. Xu B, Goulding EH, Zang K, et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nature Neuroscience. 2003;6:736
  38. Yeo GS, Connie Hung CC, Rochford J, et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nature Neuroscience. 2004;7:1187
  39. Gray J, Yeo G, Hung C, et al. Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity. International Journal of Obesity (London). 2006;Epub ahead of print
  40. Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88:131
  41. Cone RD. The melanocortin-4 receptor. In:  Cone RD editors. The melanocortin receptors. 1st edn.. Totowa, New Jersey: Humana Press; 2000;p. 405
  42. Vaisse C, Clement K, Guy-Grand B, et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nature Genetics. 1998;20:113
  43. Yeo GS, Farooqi IS, Aminian S, et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nature Genetics. 1998;20:111
  44. Govaerts C, Srinivasan S, Shapiro A, et al. Obesity-associated mutations in the melanocortin 4 receptor provide novel insights into its function. Peptides. 2005;26:1909
  45. Carroll L, Voisey J, van Daal A. Gene polymorphisms and their effects in the melanocortin system. Peptides. 2005;26:1871
  46. Heid IM, Vollmert C, Hinney A, et al. Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. Journal of Medical Genetics. 2005;42:e21
  47. Lubrano-Berthelier C, Le Stunff C, Bougneres P, et al. A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans. The Journal of Clinical Endocrinology and Metabolism. 2004;89:2028
  48. Farooqi IS, Yeo GS, Keogh JM, et al. Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. The Journal of Clinical Investigation. 2000;106:271
  49. Farooqi IS, Keogh JM, Yeo GS, et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. The New England Journal of Medicine. 2003;348:1085
  50. Elefteriou F, Ahn JD, Takeda S, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 2005;434:514
  51. Ahn JD, Dubern B, Lubrano-Berthelier C, et al. Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency. Endocrinology. 2006;147:3196
  52. Branson R, Potoczna N, Kral JG, et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. The New England Journal of Medicine. 2003;348:1096
  53. Lubrano-Berthelier C, Dubern B, Lacorte JM, et al. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship and lack of association with binge eating. The Journal of Clinical Endocrinology and Metabolism. 2006;91:1811–1818
  54. Hinney A, Bettecken T, Tarnow P, et al. Prevalence, spectrum and functional characterization of melanocortin-4 receptor gene mutations in a representative population-based sample and obese adults from Germany. The Journal of Clinical Endocrinology and Metabolism. 2006;91:1761–1769
  55. Vaisse C, Clement K, Durand E, et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. The Journal of Clinical Investigation. 2000;106:253
  56. Lubrano-Berthelier C, Cavazos M, Dubern B, et al. Molecular genetics of human obesity-associated MC4R mutations. Annals of the New York Academy of Sciences. 2003;994:49
  57. Nijenhuis WA, Oosterom J, Adan RA. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Molecular Endocrinology (Baltimore, Md.). 2001;15:164
  58. Srinivasan S, Lubrano-Berthelier C, Govaerts C, et al. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. The Journal of Clinical Investigation. 2004;114:1158
  59. Tao YX. Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Molecular and Cellular Endocrinology. 2005;239:1
  60. Chen AS, Marsh DJ, Trumbauer ME, et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nature Genetics. 2000;26:97
  61. Feng N, Young SF, Aguilera G, et al. Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes. 2005;54:2663
  62. Tao YX, Segaloff DL. Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation. The Journal of Clinical Endocrinology and Metabolism. 2004;89:3936
  63. Hebebrand J, Friedel S, Schauble N, et al. Perspectives: molecular genetic research in human obesity. Obesity Reviews. 2003;4:139
  64. Shmulewitz D, Heath SC, Blundell ML, et al. Linkage analysis of quantitative traits for obesity, diabetes, hypertension, and dyslipidemia on the island of Kosrae, Federated States of Micronesia. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:3502
  65. Rankinen T, Zuberi A, Chagnon YC, et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring). 2006;14:529
  66. Meyre D, Bouatia-Naji N, Tounian A, et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nature Genetics. 2005;37:863
  67. Saar K, Geller F, Ruschendorf F, et al. Genome scan for childhood and adolescent obesity in German families. Pediatrics. 2003;111:321
  68. Dong C, Li WD, Li D, et al. Interaction between obesity-susceptibility loci in chromosome regions 2p25-p24 and 13q13-q21. European Journal of Human Genetics. 2005;13:102–108
  69. Suviolahti E, Ridderstrale M, Almgren P, et al. Pro-opiomelanocortin gene is associated with serum leptin levels in lean but not in obese individuals. International Journal of Obesity and Related Metabolic Disorders. 2003;27:1204
  70. Boutin P, Dina C, Vasseur F, et al. GAD2 on chromosome 10p12 is a candidate gene for human obesity. PLoS Biology. 2003;1:E68
  71. Durand E, Boutin P, Meyre D, et al. Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians. Diabetes. 2004;53:2483
  72. Abate N, Chandalia M, Satija P, et al. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes. 2005;54:1207
  73. Grarup N, Urhammer SA, Ek J, et al. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia. 2006;49:2097
  74. Swarbrick MM, Waldenmaier B, Pennacchio LA, et al. Lack of support for the association between GAD2 polymorphisms and severe human obesity. PLoS Biology. 2005;3:e315
  75. Hunt SC, Xin Y, Wu LL, et al. Lack of association of glutamate decarboxylase 2 gene polymorphisms with severe obesity in utah. Obesity (Silver Spring). 2006;14:650
  76. Tiwari HK, Allison DB. Do allelic variants of SLC6A14 predispose to obesity?. The Journal of Clinical Investigation. 2003;112:1633
  77. Laird NM, Lange C. Family-based designs in the age of large-scale gene-association studies. Nature Reviews. Genetics. 2006;7:385
  78. Abiola O, Angel JM, Avner P, et al. The nature and identification of quantitative trait loci: a community's view. Nature Reviews. Genetics. 2003;4:911
  79. Herbert A, Gerry NP, McQueen MB, et al. A common genetic variant is associated with adult and childhood obesity. Science. 2006;312:279
  80. Gallou-Kabani C, Junien C. Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic. Diabetes. 2005;54:1899
  81. Verdich C, Clement K, Sorensen TI. Nutrient-gene interactions in the control of obesity. Functional foods, aging and degenerative disease. 10. 2004;p. 219
  82. Luan J, Browne PO, Harding AH, et al. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes. 2001;50:686
  83. Meirhaeghe A, Helbecque N, Cottel D, et al. Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet. 1999;353:896
  84. Lindi V, Sivenius K, Niskanen L, et al. Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia. 2001;44:925
  85. Otabe S, Clement K, Dina C, et al. A genetic variation in the 5' flanking region of the UCP3 gene is associated with body mass index in humans in interaction with physical activity. Diabetologia. 2000;43:245
  86. NUGENOB. www.nugenob.com.
  87. DIOGENES. www.diogenes-eu.org.
  88. Ardlie KG, Lunetta KL, Seielstad M. Testing for population subdivision and association in four case-control studies. American Journal of Human Genetics. 2002;71:304
  89. Mutch DM, Clément K. Unraveling the genetics of human obesity. PLoS Genetics. 2006;in press

PII: S1521-690X(06)00077-7

doi: 10.1016/j.beem.2006.09.006

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 4 , Pages 647-664 , December 2006

Article Tools

* Image Usage & Resolution